Soft tissue processing
View Patent ↗The present invention is a process for preparing soft tissue such as tendons, ligaments, cartilage, fascia, dermis, human valves and human veins for implant in a human and removes cellular components and forms an decellular matrix having as major components collagens and elastins while sterilizing the tissue. The process comprises the following steps: (1) isolating from a suitable donor a desired soft tissue sample of the biological material; (2) processing and decellularizing the soft tissue including inspection for visual defects, trimming and soaking the tissue in a detergent depending on whether the tissue is fascia or dermis and rinsing same with sterile water; (3) sterilizing the soft tissue in a vacuum and soaking the tissue in an antibiotic composition or peracetic acid depending on whether the soft tissue is fascia or dermis and rinsing same; (4) processing the tissue by cutting the tissue to size and perforating the tissue; and (5) dipping the tissue in 70% ethanol and packaging the tissue.
1. A method for the treatment of human donor dermis to prepare the same for implantation into a human comprising:
(a) thawing frozen donor dermis and decellularizing the donor dermis;
(b) inspecting the donor dermis for defects;
(c) trimming the donor dermis for processing;
(d) sterilizing the trimmed donor dermis in a vacuum with a soak in a sterilization solution consisting essentially of propylene glycol, ethanol, water and peracetic acid,
(e) rinsing the material contained in the soak from the donor dermis;
(f) cutting the treated donor dermis to a specific size;
(g) immersing the cut donor dermis in ethanol; and
(h) packaging the ethanol-soaked donor dermis in a sealed package, wherein the donor dermis is flexible upon removal from the package.
2. The method as claimed in claim 1 wherein after (f), the cut dermis is perforated with a plurality of spaced apertures.
3. The method as claimed in claim 1 , further comprising adding at least one protease inhibitor during decellularization of the donor soft tissue, wherein the protease inhibitor is selected from the group consisting of: Aminoethylbenzenesulfonyl fluoride HCL (Serine Proteases), Aprotinin (broad spectrum, serine proteases), Protease Inhibitor E-64 (Cysteine Proteases), Leupeptin, Hemisulfate Cysteine Proteases and trypsin-like proteases, Pepstatin A (Aspartic Proteases), and Marmistat (MMP2).
4. The method of claim 1 , wherein prior to sterilizing the dermis in (d), decellularizing the dermis comprises:
(i) removing the epidermal layer from skin tissue;
(ii) soaking the remaining skin tissue in 1M NaCl from 1.5 to 48 hours;
(iii) rinsing the NaCl-soaked skin tissue with sterile water a plurality of times to remove the NaCl;
(iv) soaking the treated skin tissue in 0.1% Triton X-100 detergent from 1.5 to 48 hours; and,
(v) rinsing the Triton X-100 detergent-soaked skin tissue with sterile water to remove the detergent to an acceptable level.
5. The method of claim 4 , further comprising adding at least one protease inhibitor during decellularization of the dermis, wherein the protease inhibitor is selected from the group consisting of: Aminoethylbenzenesulfonyl fluoride HCL (Serine Proteases), Aprotinin (broad spectrum, serine proteases), Protease Inhibitor E-64 (Cysteine Proteases), Leupeptin, Hemisulfate Cysteine Proteases and trypsin-like proteases, Pepstatin A (Aspartic Proteases), and Marmistat (MMP2).
6. The method of claim 1 , wherein the soft donor tissue is soaked in the sterilization solution for about 4 to 8 hours.
7. The method of claim 4 , wherein the dermis is soaked in the sterilization solution for about 4 to 8 hours.
8. Dermis tissue prepared according to the method of claim 1 .
9. Dermis prepared according to the method of claim 4 .
10. The method of claim 1 , wherein the sterilization solution in (d) comprises 35% peracetic acid.
11. The method of claim 4 , wherein the remaining skin tissue in (ii) is soaked in 1M NaCl from 12-48 hours.
12. The method of claim 4 , wherein the treated skin tissue in (iv) is soaked in 0.1% Triton X-100 from 24-48 hours.
13. The donor soft tissue of claim 8 , wherein the tissue is less than 1.0 mm thick.
14. The method of claim 1 , wherein prior to sterilizing the dermis in (d), decellularizing the dermis comprises:
(i) removing the epidermal layer from skin tissue;
(ii) soaking the remaining skin tissue in 1M NaCl and 0.1% Triton X-100 detergent from 1.5 to 48 hours;
(iii) rinsing the skin tissue from (ii) with sterile water a plurality of times to remove the NaCl and detergent to an acceptable level.